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Abstract
In the article is considered the problem of support of Sudan population with available pharmaceutical production. 
The aim of research is an analysis of the price and assortment policy realized by the different pharmaceutical structures, 
determination of the level of their functions on guaranteeing the availability of medicaments, elaboration on the base of 
received results the arrangements on optimization of the pharmaceutical support system. It was determined that not all 
subjects of Sudan pharmaceutical market responsible for the pharmaceutical support cope with such problems at the prop-
er level. Thus in the private drugstores, in the net drugstores of the Ministry of defense «Alia» and in drugstores of the 
health insurance system the prices of medicament exceed the recommended ones in more than 2 times, an assortment also 
does not corresponds to both internal and international requirements. The received results indicate the unreasonable use 
of budget means by the separate state structures, the negative tendencies in the system of guaranteeing the availability of 
pharmaceutical help. 
It was established that the biggest suppliers of the medicaments in Sudan, excluding the state Centre of 
medicament support CMS cannot ensure the system of health protection with medicaments of the proper quality, 
assortment and the price rate. 
There were elaborated the organizational-economic approaches to optimization of the structure of medical support 
of Sudan that include the change of the flows of medicaments distribution. There was offered the structure that unites all 
inflows in the aforesaid CMS and then distributes resources according to the needs of organizations and regions. 
Introduction of the offered structures will allow improve the system of purchase and distribution of medicaments, 
make it transparent. The result of change will be the rise of physical and economic availability of medicaments, widening 
of assortment, decrease of the price of preparations, significant economy of budget resources. 
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1. Introduction
For today pharmaceutical sector in Sudan suffers from the numerous problems [1–3], 
which solving is interfered by the lack of financial, material and human resources. Sudan phar-
maceutical enterprises produce mainly generic medicaments. The state support of the native 
producers has mainly declarative character, is not confirmed with legislative acts that results in 
fact that enterprises lose the competitive fight with the foreign pharmaceutical companies [4–6]. 
This situation needs for elaboration of the rational approaches to the change of existing system 
of pharmaceutical help. 
The main representatives of the state system of medicament support are the following struc-
tures: Centre of medical support (CMS); State revolving drugs fund (RDF); pharmaceutical sub-
division Elamal within the service of security and protection; pharmaceutical subdivision Alia 
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within the Sudan Ministry of defense. They all are financed from the state budget and was created 
or authorized for guaranteeing the proper level of availability of pharmaceutical help. But over time 
it became obvious that the aforesaid structures not equally succeed in their duties. The medicament 
support system is also formed with the drugstores of private sector, medical insurance systems and 
donor organization (charity funds and so on). 
According to the data from the certain sources, more than 46 % of population in Sudan is 
beyond the poverty line [1], the level of morbidity and mortality is high [3]. The country has an ur-
gent need for qualified medical specialists [3], equipment [7], medicaments [8, 9]. The most part of 
population pays for the services of the state and private institutions from the own pocket. The share 
of households with catastrophic outcomes for health protection increased up to 70 % last years [10]. 
This situation raises the vulnerability of the wider population in the aspect of availability of the 
medical and pharmaceutical help. 
Since 2000 Sudan government accepted several legislative acts, the main one is Nation-
al medicament policy of Sudan [11, 12], that regulates the circulation and, especially, prices for 
medicaments in both state and private sectors. According to the discussions about prices for the 
medicaments and their availability in the Eastern Mediterranean region carried out by the World 
health protection organization (WHO) [13, 14] and Regional bureau of the Eastern Mediterranean 
countries [15, 16], prices for medicaments in Sudan are the one of the highest in the region. 
The separate theoretical and practical questions as to the factors that influence an activity 
of health protective institutions in African and other countries are considered all over the world. 
Thus M. Khalid in his work [17] carried out an analysis of the price discrepancies and determined 
the factors of environment and the degree of their influence on the rational use of medicaments. 
K. M. Gamal [18] outlined the prospects of the native importers at introduction of the more severe 
rules for guaranteeing the proper quality of medicaments. Salah Ibrahim Kheder [19] in his works 
also analyzes the price policy of the different subjects of pharmaceutical market, presence and 
availability of medicaments and the price components. The questions of regulation of pharmaceu-
tical sphere in African countries are elucidated in the annual reports of the World health protection 
organization [6, 20, 21], Centre of strategic and international studies (USA) [22] and other literature 
sources [23, 24], founded in the UN program “the millennium aims in development” [25]. But for 
today we can observe the deficiency of the properly structured data on the assortment and prices 
for medicaments and also the limited number of elaborations as to analysis of existing structure of 
supply and its optimization. 
2. Aim of research
Analysis of the price and assortment policy realized by the different pharmaceutical struc-
tures, determination of the level of their functioning on guaranteeing the availability of medica-
ments, elaboration of the arrangements as to optimization of the pharmaceutical help system on the 
base of the received results. 
3. Materials and methods
The tasks of research were in determination and analysis of the present assortment and 
prices for the selected groups of medicaments and in understanding of the dependence of prices on 
the levels of medicament support system. As the reference point for comparison was taken WHO 
Model List of Essential Medicines − EML. 
The research was carried out during 2015 in Sudan. In the work was used the statistical, 
comparative and quantitative market analysis of pharmaceutical market. In particular, were stud-
ied an assortment and prices for medicaments supplied by the leading pharmaceutical organiza-
tions of Sudan. The part of these organizations has the budget financing. With the help of results 
of the market studies, results of content-analysis [26, 27] and on the base of structural analysis 
was offered the optimized organizational structure of the management of Sudan pharmaceutical 
sector that presupposes the changes just in the section of pharmaceutical support (supply and 
distribution system). 
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4. Results of research
The first stage of research was an analysis of the medicaments assortment in the main sub-
jects of pharmaceutical market, especially: drugstores of the Centre of medical supply CMS, drug-
stores of the private sector, medical insurance system and also the system of medicament support of 
the armed forced of the country (drugstore net «Alia»). It is worth noting, that the Centre of medical 
support and system of medicament support of the Sudan armed forces have the budget financing. 
The other structures were not considered because of insignificant circulation of medicaments. The 
received results presented in Table 1. 
Table 1
Correspondence of medicaments assortment in the objects of Sudan pharmaceutical support to the 
criteria recommended by WHO 
Medicaments  
assortment in  
correspondence with 
the recommended 
list «WHO essential  
medicine list»
Medicaments assortment in the drugstore nets of the country 
CMS Private sector Medical insurance system
Armed forces system 
(departmental  
drugstore net «Alia»)
number share, % number
Share relative 
to the recom-
mended list, %
number
Share relative 
to the recom-
mended list, %
number
Share relative 
to the recom-
mended list, %
number
Share relative 
to the recom-
mended list, %
399 100 237 59.40 198 49.62 97 24.31 71 18.00
The next stage of research was an analysis of the price policy in aforesaid organiza-
tions during the year. The collection of data was carried out 4 times a year (1 time a quarter); 
the mean arithmetic indices took part in the research. The results of research are presented in 
the Table 2. 
The basic index in this case were prices in CMS drugstores compared with prices for anal-
ogous goods in other system organizations. 
Table 2
Mean basic indices of growth/decrease of prices in the leading organizations of Sudan medicament 
support system 
Mean basic indices of growth/decrease of retail prices in the different structural subdivisions of  
Sudan medicament support system, kb
 CMS drugstores
Net drugstores of the  
Ministry of defense «Alia»
Medical insurance drugstores Private drugstores
1 1,87 1,89 2,1
On the base of the research and analysis of scientific publications [20, 23, 24, 26, 27] was 
offered the optimized structural scheme of the medicament support in Sudan (Fig. 1, 2).
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Fig. 1. Existing organizational structure of the management of Sudan pharmaceutical sector 
Fig. 2. Offered organizational structure of the management of Sudan pharmaceutical sector 
5. Discussion of the results of research
Comparing the assortments of aforesaid organizations with the model list of the main 
medicaments recommended by WHO (it includes 399 names) we can note the following. 
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The drugstores of CMS system provide 59,40 % of the assortment recommended by WHO, 
drugstores of the private sector – 49,62 %, drugstores of the medical insurance − 24,31 %, 
and the drugstore net of the armed forces system of the country “Alia” provide 18,00 % of 
the recommended points. So, the state system of distribution provides near 60 % of the nec-
essary assortment, private sector also provides the rather wide spectrum of medicaments – 
near 50 %, and the medical insurance and the armed forces systems of the country practi-
cally cannot cope with the problem. It was established, that the system of state support 
CMS in addition to the main list has the lists of medicaments that are present also in the 
lists of such organizations as UNICEF and UNDPE (UN programs of development). CMS 
deals with receipt of medicaments from the donor organizations, storage and distribution 
free of charge within the programs accepted at the state level. Most of these preparations 
are aimed at the treatment of the socially significant diseases such as malaria, tuberculosis, 
AIDS (near 340 names). 
At analysis of the price policy realized by these subjects of pharmaceutical market of 
Sudan was determined that the highest prices were registered in the private drugstores – it 
exceeds the ones of CMS drugstores more than by 100 % in average. The unreasonably high 
prices are in the net drugstores of the Sudan Ministry of defense “Alia” and in ones of the 
medical insurance system – their indices indicate the unsatisfactory organizational measures 
on guaranteeing the availability of medicaments – excess is near 90 %. 
Thus all organizations except CMS cannot be the main structures that supply the health 
protection system with medicaments of proper quality, assortment and price indices. This 
question is especially urgent at consideration of the support system of the Ministry of de-
fense that functions due to the budget means and, consequently, uses its rather small resources 
irrationally. 
In the further the development of the following directions of this research is possible – 
separate analysis of the presence and prices of original and generic preparations, monitoring 
of prices at the different levels of goods circulation (wholesale and retail link) and also the 
comparative analysis of the aforesaid indices in the different geographic zones of Sudan. So, 
the analysis of the cheap generics will allow determine the level of economic availability of 
medicaments in the country and analysis of the presence and availability of original prepara-
tions will allow make conclusions about how spread are the last achievements of pharmaceuti-
cal science and how difficult to get an access to them. 
Unfortunately, the Sudan state system of medicament support is characterized with 
decentralized management of purchases and supplies of medicaments. Many state structures 
(army, police and so on) often make the direct purchases at the private enterprises, pharma-
ceutical factories, in dealers of the foreign companies. Such decentralization when the state 
wholesale pharmaceutical organization – Centre of medical support CMS – does not partic-
ipate in this process is economically unprofitable for the state. It favors the conditions for 
misuses and conflict situations. The assortment of these organizations does not correspond 
to the minimal requirements, the retail prices are overestimated in few times (that testifies 
to the permanent violation of the law or organization of illegal schemes in the drugstore 
work) that result in the decrease of availability of pharmaceutical help in the country where 
the infectious and other disease are widespread and the lion’s share of population is beyond 
the poverty line. 
We carried out analysis of the structure and activity of the state system of the Revolv-
ing Drug Fund (RDF), Center of medical support (CMS) and system of support of the Sudan 
Ministry of defense. The literature sources [23–27] indicate the problems at the simultaneous 
functioning of RDF and CMS. The main one – at purchases of medicaments and their distri-
bution RDF often acts as a parallel structure that duplicates the functions of CMS. Analysis 
of assortment and price policy showed that the system of support of the Ministry of defense 
also does not cope with the set problems: prices for preparations are overestimated (corruption 
component), assortment does not correspond to the minimal requirements, complications with 
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an access to the pharmaceutical storages and drugstores (the access of pharmaceutical inspec-
tion is limited), the function of the main state supplier are duplicated. 
The research showed that it is expedient to choose the centralization of the medicament 
support system as the priority direction of the improvement of structure of Sudan state sector 
of pharmaceutical market. 
At introduction of the new model of medicament support system the following results 
are expected:
– economy of budget means, decrease of the number of misuses;
– formation of the unite approach to the guaranteeing of the proper quality of medica-
ment, distribution, transporting, warehousing and storage (at the expense of compliance with 
GSP, GDP requirements);
– elimination of duplicated functions by the main organizations-suppliers of medicaments;
– introduction of the unite system of reporting (rise of the distinctness of the received 
data, clearness in the work of purchases distribution and prognostication systems);
– economy of accommodations for the medicaments storage, reduction of the transport 
outcomes, diminishing of the number of staff for the system maintenance;
– unite approach to the selection and teaching of the workers (qualified and motivated staff);
– rise of effectiveness of solving questions of the rational use of medicaments and phar-
maceutical surveillance; 
– decrease of the number of falsified and bad pharmaceutical production in circulation;
– reorganization of the work on purposeful programs on the fight against malaria, HIV\AIDC 
(rise of the effectiveness of these working directions). 
Thus, there were offered the organizational-economic approaches to optimization of the 
structure of Sudan medicament support that will raise the effectiveness of the existing systems 
of purchase and distribution of medicaments, have a positive effect on physical and economic 
availability of pharmaceutical help. 
6. Conclusions
1. There was carried out an analysis and monitoring of the price policy in the different 
subjects of the Sudan medicament support system that demonstrated the following:
– the highest prices were fixed in the private drugstores – the mean basic indices of the 
growth\decrease of retail prices relative to the ones of Centre of medicament support (CMS) − 2,1;
– the indices of the net drugstores of Sudan Ministry of defense “Alia” and the ones 
of the medical insurance system indicate the unsatisfactory organizational arrangements on 
guaranteeing the medicaments availability –the mean basic indices of growth/decrease of pric-
es are 1,87 and 1,89 respectively.
The results indicate the irrational use of budget means by the separate state structures, 
the negative results of the work on guaranteeing the pharmaceutical help availability. 
2. There were elaborated organizational-economic approaches to optimization of Sudan 
medicament support structure that include the change of flows of medicament distribution. 
There was offered the structure that unifies all inflows in the state company CMS (Sudan 
Centre of medicament support) and then distributes the resources according to the needs of 
organizations and regions. 
3. Introduction of the offered arrangements will allow essentially improve the exist-
ing systems of medicaments purchase and distribution, control these processes, make them 
transparent. 
There was offered the rise of physical and economic availability of pharmaceutical help 
by the way of widening of assortment, lowering of the price for medicaments almost in 2 times, 
strengthening of the control on the quality and safety of the used preparations. 
At macro level the morbidity and mortality rates will be lowered, the health status and 
life quality of nation will improved, the significant economy of both state and own patient’s 
savings will be attained. 
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